Evidence map›Paper›PMID 30814495›Full record

ArticleCell death & disease2019

The intracellular domain of β-dystroglycan mediates the nucleolar stress response by suppressing UBF transcriptional activity.

Paulina Margarita Azuara-Medina, Ariana María Sandoval-Duarte, Sara L Morales-Lázaro, Ricardo Modragón-González, Griselda Vélez-Aguilera, Juan de Dios Gómez-López, Guadalupe Elizabeth Jiménez-Gutiérrez, Reynaldo Tiburcio-Félix, Ivette Martínez-Vieyra, Rocío Suárez-Sánchez and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Analysis of Beta-Dystroglycan in Different Cell Models of Senescence.International journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 4 countries.

Paulina Margarita Azuara-MedinaDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07360, Ciudad de México, Mexico.
Ariana María Sandoval-DuarteDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07360, Ciudad de México, Mexico.
Sara L Morales-LázaroDepartamento de Neurociencia Cognitiva, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510, Ciudad de México, Mexico.
Ricardo Modragón-GonzálezDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07360, Ciudad de México, Mexico.
Griselda Vélez-AguileraDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07360, Ciudad de México, Mexico.
Juan de Dios Gómez-LópezDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07360, Ciudad de México, Mexico.
Guadalupe Elizabeth Jiménez-GutiérrezDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07360, Ciudad de México, Mexico.
Reynaldo Tiburcio-FélixDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07360, Ciudad de México, Mexico.
Ivette Martínez-VieyraLaboratorio de Hematobiología, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, 07320, Ciudad de México, Mexico.
Rocío Suárez-SánchezLaboratorio de Medicina Genómica, Instituto Nacional de Rehabilitación, 14389, Ciudad de México, Mexico.
Gernot LängstBiochemistry Centre Regensburg (BCR), Universität Regensburg, 93053, Regensburg, Germany.
Jonathan Javier MagañaLaboratorio de Medicina Genómica, Instituto Nacional de Rehabilitación, 14389, Ciudad de México, Mexico.
Steve J WinderDepartment of Biomedical Science, University of Sheffield, Sheffield, S10 2TN, UK.
Arturo OrtegaDepartamento de Toxicología, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07000, Ciudad de México, Mexico.ORCID http://orcid.org/0000-0002-9594-8114
Rita de Cassia Ramos PerlingeiroDepartment of Medicine, Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, USA.
Laura A JacobsDepartment of Biomedical Science, University of Sheffield, Sheffield, S10 2TN, UK.
Bulmaro CisnerosDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados Del Instituto Politécnico Nacional, 07360, Ciudad de México, Mexico. bcisnero@cinvestav.mx.ORCID http://orcid.org/0000-0003-2802-1201
Instituto Politécnico Nacional · MXInstituto Nacional de Rehabilitación · MXUniversity of Sheffield · GBUniversidad Nacional Autónoma de México · MXUniversity of Minnesota · USUniversity of Regensburg · DE

Funding

Medical Research Council G1000405-1/1Medical Research Council MR/J500513/1
6 · The paper itself

Abstract

β-dystroglycan (β-DG) is a key component of multiprotein complexes in the plasma membrane and nuclear envelope. In addition, β-DG undergoes two successive proteolytic cleavages that result in the liberation of its intracellular domain (ICD) into the cytosol and nucleus. However, stimuli-inducing ICD cleavage and the physiological relevance of this proteolytic fragment are largely unknown. In this study we show for the first time that β-DG ICD is targeted to the nucleolus where it interacts with the nuclear proteins B23 and UBF (central factor of Pol I-mediated rRNA gene transcription) and binds to rDNA promoter regions. Interestingly DG silencing results in reduced B23 and UBF levels and aberrant nucleolar morphology. Furthermore, β-DG ICD cleavage is induced by different nucleolar stressors, including oxidative stress, acidosis, and UV irradiation, which implies its participation in the response to nucleolar stress. Consistent with this idea, overexpression of β-DG elicited mislocalization and decreased levels of UBF and suppression of rRNA expression, which in turn provoked altered ribosome profiling and decreased cell growth. Collectively our data reveal that β-DG ICD acts as negative regulator of rDNA transcription by impeding the transcriptional activity of UBF, as a part of the protective mechanism activated in response to nucleolar stress.

Indexed as

AnimalsCell NucleolusCell ProliferationCytoplasmDNA, RibosomalDystroglycansMiceMyoblastsNuclear ProteinsNucleophosminOxidative StressPol1 Transcription Initiation Complex ProteinsProtein DomainsRibosomesRNA, RibosomalTranscription, GeneticDNA, RibosomalDystroglycansNpm1 protein, mouseNuclear ProteinsNucleophosminPol1 Transcription Initiation Complex ProteinsRNA, Ribosomaltranscription factor UBF

Identifiers

PMID30814495
PMCPMC6393529
OpenAlexW2917595799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.